Mark Whelan (Fuming Mouth) diagnosed with acute myeloid leukemia

Mark Whelan (guitarist and vocalist of Milford, Massachusetts-based death metal and crust act Fuming Mouth) has been diagnosed with acute myeloid leukemia, a cancer of the myeloid line of blood cells. Via social media, Mark posted the above photo and below message:

Hi everyone, I was diagnosed with cancer a few weeks ago. I have acute myeloid leukemia (AML). A type of cancer that is treatable. We’ve already begun treatment and are working to beat this every day. It will surely be a hard road but I’m ready to face it.

In addition, a GoFundMe campaign has been created to help Mark with medical expenses. Here’s more info from the fundraiser:

On November 19 2021, Mark was diagnosed with an aggressive form of cancer called Acute Myeloid Leukemia (AML). This diagnosis came as a shock after a week long stay at Milford Regional Medical Center.

Mark has since been transported to Beth Israel Deaconess Medical Center, near Fenway in Boston, where he began induction chemotherapy treatment on November 26 2021.

This is just the beginning of Mark’s fight against AML. He will require extensive treatment in the upcoming months while he is hospitalized.

Mark is currently on state healthcare and much of what he will endure for treatment will not be covered by insurance. We are asking for donations to help lessen the massive financial blow of this incredibly devastating news. Anything counts and is deeply appreciated. It is highly unlikely that the goal amount will cover all of his medical bills, so any donation is welcome.

Mark’s treatment will include a bone marrow transplant. This is a procedure that depends on the availability of donors. If you’re able, please consider joining the bone marrow donor registry. It’s free and can help save someone’s life. Find more information here:

Here’s that GoFundMe link again. Sending good vibes and positive thoughts your way, Mark.

Follow NextMosh On: Facebook, Twitter, Instagram, YouTube

This post may contain referral links.

This website uses cookies, and by using this website, you consent to the use of cookies.

Leave a Reply

Your email address will not be published. Required fields are marked *